Industry Projects | Projects by Region | Projects by Category | Archived Projects | Project Gallery
 

Lorcaserin, Investigational Oral Anti-Obesity Drug



Anti obesity drug clinical trials

Arena's lorcaserin has demonstrated positive results in clinical trials and the drug is now pending FDA approval.


Back to Project Details



Related Projects

Tarceva - Small Molecule
Tarceva (erlotinib) is an oral anti-cancer drug developed by...

Erbitux (Cetuximab)
Erbitux is a chimaeric monoclonal antibody (MAb) that is specific for...

Acomplia (Rimonabant) - Investigational Agent for the Management of Obesity
Developed by Sanofi-Aventis, Acomplia (rimonabant) is a selective...

Avastin (bevacizumab) - Angiogenesis
The product of a joint development programme between Genentech and...

Rupintrivir -
Agouron Pharmaceuticals, a subsidiary of Pfizer, has pioneered...

See all projects


Twitter Twitter    Facebook Facebook   
Contact us
Advertise with us
Terms and conditions
Privacy
Links
Newsletter sign up
Online magazine sign up

drugdevelopment-technology.com is a product of Net Resources International. Copyright 2012 Net Resources International, a trading division of SPG Media Limited.